Breast Cancer Treatment in Women with PALB2 Mutations

Breast Cancer Treatment in Women with PALB2 Mutations

Researcher Kelly Metcalfe, PhD, Women’s College Research Institute, Toronto, ON, Canada Summary Research has shown that people who have inherited a mutation in the PALB2 gene are at increased risk for breast cancer. We have learned a lot about breast cancer that...
Communication & Companions in Cancer Care

Communication & Companions in Cancer Care

Researcher Kathryn Greene, PhD, Rutgers University; Katie Devine, PhD, Rutgers Cancer Institute of New Jersey; Smita Banerjee, PhD, Memorial Sloan Kettering Cancer Center; Maria Venetis, PhD, Rutgers University; Danielle Catona, PhD, George Mason University; Maria...
Predicting Brain Health After Chemotherapy

Predicting Brain Health After Chemotherapy

Researcher Shelli Kesler, PhD, University of Texas at Austin, Austin, TX Summary We need women with a history of breast cancer who have completed chemotherapy treatment at least 1 month ago and healthy women to help researchers gain a better understanding of the...
Genomic Analysis of Long-Term Survivors with Metastatic Cancer

Genomic Analysis of Long-Term Survivors with Metastatic Cancer

Researcher Mark Burkard, MD, PhD, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin Summary Some people live for many years following a metastatic breast cancer diagnosis. To gain insight into why researchers want to learn more about the medical...
Risk Factor Analysis of Hereditary Breast and Ovarian Cancer

Risk Factor Analysis of Hereditary Breast and Ovarian Cancer

Researcher Steven Narod, MD, Women’s College Research Institute, Toronto, Ontario, Canada Summary Genetic and non-genetic factors are believed to influence whether a woman with a BRCA1, BRCA2, and/or PALB2 mutation goes on to develop breast and/or ovarian...
En Español »